NEWS

Physicians Urged to Consider Active Surveillance in Prostate Cancer

The most explicit call to date for expanding the use of active surveillance in the treatment of prostate cancer was made last week by the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of leading cancer centers. Updated guidelines from the group urge clinicians to offer active surveillance to their patients with prostate cancers that are at low risk of progressing to life-threatening disease. Read more > >

• Study Weighs Comparative Effectiveness of Low-risk Prostate Cancer Treatments

  For low-risk men, active surveillance and immediate treatment with surgery or radiation provided equivalent cancer outcomes

• Lenalidomide Helps Delay Progression of Multiple Myeloma

  The drug produced as much as a 58 percent reduction in the risk of disease progression

• Genetic Study of Lymphoma Tumors Points to Possible Therapies

  In the lab, an approved leukemia drug selectively kills lymphoma cells

• Vaccine Kills Residual Leukemia Cells in Patients Treated with Imatinib

  Complete molecular response observed in more than a third of patients in a small trial

• Cancer Cells Use Stored Fats to Fuel Aggressive Growth and Spread

  Findings offer potential molecular clues linking diet, obesity to tumor behavior

COMMENTARY

Guest Director's Update: Targeting Barriers, including Insurance Coverage, to Improve Clinical Trial Participation

by Andrea Denicoff and Dr. Jeffrey Abrams

Lack of health insurance coverage for the routine cost of care for patients taking part in clinical trials—including doctor visits, hospital stays, clinical laboratory tests, and other expenses—is a major barrier to participation. Read more > >

Guest Commentary by Brenda Nevidjon: Health Care Changes—How Cancer Care Initiatives Can Help

The president of the Oncology Nursing Society describes initiatives in oncology nursing that may be a model of the health care system Read more > >